Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
The APOE gene, which codes for a fat-binding protein in the brain, is identified as a strong genetic risk factor for the most common form of the disease.
A survey of early-career academics finds that one in four is considering moving abroad amid concerns of stigmatization from some international colleagues.
The protein tau is identified as the core component of neurofibrillary tangles — nearly 80 years after the structures were spotted in the brains of people with Alzheimer’s disease.